Dr. Christopher Gogan Manschreck, MD

Dr. Manschreck practices at University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico.

Dr. Manschreck's NPI, 1962933069, was assigned on March 21, 2017. Dr. Manschreck holds New Mexico license MD2022-0573.

Dr. Manschreck's primary practice is University of New Mexico Hospital, at 2211 Lomas Boulevard NE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 272-2111.

Dr. Manschreck's primary practice is University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico. Dr. Manschreck is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is UNM Medical Group, Inc. Dmand AI also links Dr. Manschreck to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Manschreck practices, 3 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Manschreck's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dmand AI has Dr. Manschreck's licenses on file in 2 states: New Mexico and New York.

CMS data shows 104 Medicare services from Dr. Manschreck across 1 procedure code in 2024, for 79 Medicare patients. Medicare paid $6,763 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 79 Medicare patients who saw Dr. Manschreck in 2024. The largest group is under 65, with 33 patients. 75% of them have anxiety, and 72% have mood disorders. 57% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Manschreck's median patient age at 67, with 46% women.

In 2024, Dr. Manschreck wrote 168 Medicare Part D claims for 36 patients. 98% of them were for generic drugs. CMS names the drug for 68 of them, across 5 drugs with 11 or more claims each, at $700 in total drug cost. In 2023, CMS named 29 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Manschreck for performance year 2024, reported as part of a group. Dr. Manschreck accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Manschreck as offering telehealth.